Tag: Johnson and Johnson

All

FDA Authorizes Moderna and Janssen Boosters

The FDA authorized single booster doses for the Moderna Inc and Janssen COVID-19 vaccines for certain adults age 18 and older, as well as the use of "mix and match" boosters of differing vaccines.

FDA Approves Rybrevant for Certain NSC Lung Cancer Patients
Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations
FDA and CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine
US to Halt Johnson & Johnson Vaccine Over Unexplained Blood Clots
How Does the Johnson & Johnson Vaccine Compare to Other Coronavirus Vaccines?
FDA Analysis Confirms J&J COVID-19 Vaccine Prevents Severe Disease
J&J Submit COVID-19 Vaccine for FDA Authorization

All

J&J Single-dose Vaccine 85% Effective Preventing Severe COVID-19

The vaccine candidate had an 85% overall efficacy at preventing severe disease 28 days after vaccination and a 66% overall efficacy rate in preventing moderate-to-severe COVID-19.